论文部分内容阅读
Sodium tanshinone ⅡA sulfonate (STS) is a water-soluble derivative of tanshinone ⅡA, the major lipophilic component extracted from the root of Danshen (Salvia miltiorrhiza).STS is clinically used in the treatment of myocardial infarction,coronary artery disease and other cardiovascular disorders.It has been found in recent years that STS protected the heart against pathological hypertrophy in laboratory animals.However, the direct molecular targets of STS on cardiomyocytes are still unclear.Here we examined the effect of STS on the activity of TRPC channels, which have been suggested to be important mediators of pathological cardiac hypertrophy.